After Gonzalez Scandal Analyst Thinks Roche Should Scoope-Up AbbVie

Quote








You guys arn't getting this at all. The whole reason Gonzalez wanted back in to run the spin off is because they know there will be another company taking over. This was part of the stategy to come back in and disclose he had no degree. The buyout will be huge when Abbivie is taken over and he is paid off. This is all a plan to scam shareholders out of millions. Its all planned out in advance!
 




<i>Holford outlined two potential transactions. The first would be a buyout of AbbVie, an acquisition he projects as a $69 per share, $105 billion acquisition (based on a 25% premium to Jefferies' $55 per share, $84 billion valuation of the entity when it is spun out of Abbott).</i>

This right here makes this 'analyst' suspect. The valuation for AbbVie isn't going to be anywhere near $84B. Abbott's Market cap is $105, and the stock is currently near $70, figuring half of that will be what AbbVie's worth should be, give or take.

No-one would buy us at $105B. It's an idiotic statement.
 




Anonymous said:
You guys arn't getting this at all. The whole reason Gonzalez wanted back in to run the spin off is because they know there will be another company taking over. This was part of the stategy to come back in and disclose he had no degree. The buyout will be huge when Abbivie is taken over and he is paid off. This is all a plan to scam shareholders out of millions. Its all planned out in advance!
Click to expand...

Ooooooooooooohhhhhhhh. Hmmm. Could be. I wouldn't be surprised. If that's it and the cat's out of the bag, then the titanic is already leaning hard.
 








Top Bottom
Back
Quote